Ingevity Corporation (NYSE:NGVT) Given Consensus Recommendation of “Hold” by Analysts

Ingevity Corporation (NYSE:NGVT) has received a consensus rating of “Hold” from the five analysts that are currently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, two have given a hold recommendation and two have given a buy recommendation to the company. The average 12-month price objective among brokers that have issued a report on the stock in the last year is $80.00.

Several equities research analysts have recently weighed in on NGVT shares. Wall Street Zen raised shares of Ingevity from a “hold” rating to a “strong-buy” rating in a report on Saturday, May 9th. BMO Capital Markets reissued an “outperform” rating and set a $83.00 price objective on shares of Ingevity in a report on Monday, March 2nd. Jefferies Financial Group reissued a “buy” rating and set a $82.00 price objective on shares of Ingevity in a report on Thursday, February 26th. Weiss Ratings reissued a “sell (d-)” rating on shares of Ingevity in a report on Tuesday, April 21st. Finally, Wells Fargo & Company increased their price objective on shares of Ingevity from $65.00 to $75.00 and gave the stock an “equal weight” rating in a report on Friday, February 27th.

Insider Buying and Selling

In other Ingevity news, SVP Terrance M. Dyer sold 496 shares of the stock in a transaction dated Thursday, May 28th. The shares were sold at an average price of $68.49, for a total transaction of $33,971.04. Following the sale, the senior vice president owned 7,202 shares of the company’s stock, valued at $493,264.98. This represents a 6.44% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.88% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Ingevity

Hedge funds have recently added to or reduced their stakes in the stock. Global Retirement Partners LLC bought a new stake in Ingevity during the 4th quarter worth about $27,000. Meeder Asset Management Inc. acquired a new position in Ingevity during the 4th quarter valued at about $33,000. Geneos Wealth Management Inc. lifted its position in Ingevity by 85.8% during the 2nd quarter. Geneos Wealth Management Inc. now owns 838 shares of the company’s stock valued at $36,000 after purchasing an additional 387 shares during the period. Headlands Technologies LLC acquired a new position in Ingevity during the 2nd quarter valued at about $46,000. Finally, Kestra Advisory Services LLC acquired a new position in Ingevity during the 4th quarter valued at about $47,000. Institutional investors own 91.59% of the company’s stock.

Ingevity Stock Down 0.2%

NGVT opened at $65.96 on Friday. The firm’s 50-day simple moving average is $71.55 and its 200-day simple moving average is $66.34. The company has a debt-to-equity ratio of 27.83, a quick ratio of 0.92 and a current ratio of 1.42. Ingevity has a twelve month low of $39.74 and a twelve month high of $79.29. The firm has a market cap of $2.29 billion, a price-to-earnings ratio of -18.58 and a beta of 1.18.

Ingevity (NYSE:NGVT) last posted its earnings results on Wednesday, May 6th. The company reported $1.15 earnings per share for the quarter, topping the consensus estimate of $0.84 by $0.31. Ingevity had a negative net margin of 10.55% and a positive return on equity of 207.82%. The business had revenue of $258.00 million for the quarter, compared to analyst estimates of $254.73 million. During the same quarter in the prior year, the firm earned $1.01 EPS. The firm’s quarterly revenue was up 4.1% compared to the same quarter last year. Ingevity has set its FY 2026 guidance at 4.700-5.200 EPS. Equities research analysts anticipate that Ingevity will post 5.05 EPS for the current fiscal year.

About Ingevity

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.